Atlas Trials

Hepacivirus

10 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Hepacivirus

RecordFirmDate
Three-year Follow-up of Participants After Administration of Boceprevir or Narlaprevir for the Treatment of Chronic Hepatitis C (P05063) (NCT00689390)Merck Sharp & Dohme LLC2007-02-20
Treatment of Patients With Chronic Hepatitis C With PegIntron as Monotherapy or in Combination With Ribavirin (Study P04437)(COMPLETED) (NCT00705666)Merck Sharp & Dohme LLC2006-02-01
Efficacy and Safety of PegIntron Plus Ribavirin for Treatment of Chronic Hepatitis C in HIV-Infected Subjects (Study P04469)(TERMINATED) (NCT00687544)Merck Sharp & Dohme LLC2005-12-01
Satisfaction in Patients Receiving the PegIntron Pen Plus Rebetol for Hepatitis C (Study P04244)(COMPLETED) (NCT00705263)Schering-Plough2005-10-01
Adherence in Patients Receiving PegIntron/Rebetol for Hepatitis C in Conjunction With a Psychotherapy Support Program (Study P04252) (NCT00723892)Merck Sharp & Dohme LLC2005-07-01
Adherence in Patients Receiving PegIntron Pen/Rebetol for Hepatitis C in Conjunction With a Patient Assistance Program (Study P04281)(COMPLETED) (NCT00704522)Merck Sharp & Dohme LLC2005-03-01
Adherence in Patients Receiving PegIntron and Rebetol for Hepatitis C in Conjunction With a Patient Assistance Program (Study P04206) (NCT00723879)Merck Sharp & Dohme LLC2004-10-01
Retrovirus Epidemiology Donor Study-II (REDS-II) (NCT00097006)National Heart, Lung, and Blood Institute (NHLBI)2004-09-01

Track Hepacivirus automatically

Every clearance here is in the API, with alerts when new ones post.